226 related articles for article (PubMed ID: 7640156)
1. Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine.
Szumlanski CL; Weinshilboum RM
Br J Clin Pharmacol; 1995 Apr; 39(4):456-9. PubMed ID: 7640156
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human thiopurine methyltransferase by furosemide, bendroflumethiazide and trichlormethiazide.
Lysaa RA; Giverhaug T; Wold HL; Aarbakke J
Eur J Clin Pharmacol; 1996; 49(5):393-6. PubMed ID: 8866635
[TBL] [Abstract][Full Text] [Related]
3. Effects of aminosalicylates on thiopurine S-methyltransferase activity: an ex vivo study in patients with inflammatory bowel disease.
Xin H; Fischer C; Schwab M; Klotz U
Aliment Pharmacol Ther; 2005 May; 21(9):1105-9. PubMed ID: 15854172
[TBL] [Abstract][Full Text] [Related]
4. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
Bird HA
Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642
[TBL] [Abstract][Full Text] [Related]
5. Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide.
Lowry PW; Franklin CL; Weaver AL; Szumlanski CL; Mays DC; Loftus EV; Tremaine WJ; Lipsky JJ; Weinshilboum RM; Sandborn WJ
Gut; 2001 Nov; 49(5):656-64. PubMed ID: 11600468
[TBL] [Abstract][Full Text] [Related]
6. Thiopurine methyltransferase. Aromatic thiol substrates and inhibition by benzoic acid derivatives.
Woodson LC; Ames MM; Selassie CD; Hansch C; Weinshilboum RM
Mol Pharmacol; 1983 Nov; 24(3):471-8. PubMed ID: 6633508
[TBL] [Abstract][Full Text] [Related]
7. Balsalazide and azathioprine or 6-mercaptopurine.
Green JR
Gastroenterology; 1999 Dec; 117(6):1513-4. PubMed ID: 10610346
[No Abstract] [Full Text] [Related]
8. Differential effects of mesalazine formulations on thiopurine metabolism through thiopurine S-methyltransferase inhibition.
Morikubo H; Kobayashi T; Ozaki R; Okabayashi S; Kuronuma S; Takeuchi O; Shiba T; Kiyohara H; Matsubayashi M; Sagami S; Nakano M; Ikezaki O; Hisamatsu T; Tanaka Y; Hibi T
J Gastroenterol Hepatol; 2021 Aug; 36(8):2116-2124. PubMed ID: 33470487
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
[TBL] [Abstract][Full Text] [Related]
10. Human kidney thiopurine methyltransferase. Photoaffinity labeling with S-adenosyl-L-methionine.
Van Loon JA; Szumlanski CL; Weinshilboum RM
Biochem Pharmacol; 1992 Aug; 44(4):775-85. PubMed ID: 1510725
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of thiopurine methyltransferase--optimization of drug dosage and potential drug interactions.
Lennard L
Ther Drug Monit; 1998 Oct; 20(5):527-31. PubMed ID: 9780130
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human thiopurine S-methyltransferase by various nonsteroidal anti-inflammatory drugs in vitro: a mechanism for possible drug interactions.
Oselin K; Anier K
Drug Metab Dispos; 2007 Sep; 35(9):1452-4. PubMed ID: 17553913
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease.
Daperno M; Sostegni R; Canaparo R; Serpe L; Lavagna A; Crocellà L; Castagno F; Vernetto A; Rigazio C; Ercole E; D'Antico S; Pera A; Zara G; Rocca R
Aliment Pharmacol Ther; 2009 Oct; 30(8):843-53. PubMed ID: 19650826
[TBL] [Abstract][Full Text] [Related]
14. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology and pharmacogenetics of thiopurines.
Sahasranaman S; Howard D; Roy S
Eur J Clin Pharmacol; 2008 Aug; 64(8):753-67. PubMed ID: 18506437
[TBL] [Abstract][Full Text] [Related]
16. Interaction between azathioprine and aminosalicylates: an in vivo study in patients with Crohn's disease.
Dewit O; Vanheuverzwyn R; Desager JP; Horsmans Y
Aliment Pharmacol Ther; 2002 Jan; 16(1):79-85. PubMed ID: 11856081
[TBL] [Abstract][Full Text] [Related]
17. Human kidney thiopurine methyltransferase. Purification and biochemical properties.
Woodson LC; Weinshilboum RM
Biochem Pharmacol; 1983 Mar; 32(5):819-26. PubMed ID: 6838629
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of sulphasalazine, 5-aminosalicylic acid and sulphapyridine on the humoral response to antigen in vivo.
Sheldon P; Pell P
Adv Exp Med Biol; 1995; 371B():905-8. PubMed ID: 7502923
[No Abstract] [Full Text] [Related]
19. Influence of 5-aminosalicylic acid on 6-thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapy.
de Graaf P; de Boer NK; Wong DR; Karner S; Jharap B; Hooymans PM; Veldkamp AI; Mulder CJ; van Bodegraven AA; Schwab M
Br J Pharmacol; 2010 Jul; 160(5):1083-91. PubMed ID: 20590602
[TBL] [Abstract][Full Text] [Related]
20. The effects of aminosalicylic acid derivatives on nitric oxide in a cell-free system.
Reynolds PD; Middleton SJ; Shorthouse M; Hunter JO
Aliment Pharmacol Ther; 1995 Oct; 9(5):491-5. PubMed ID: 8580268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
